BR9709219A - Utilização do brometo de pinaverium na prevenção dos fenômenos proliferativos das células do trata hepatodigestivo e das doenças que daí resultam - Google Patents

Utilização do brometo de pinaverium na prevenção dos fenômenos proliferativos das células do trata hepatodigestivo e das doenças que daí resultam

Info

Publication number
BR9709219A
BR9709219A BR9709219A BR9709219A BR9709219A BR 9709219 A BR9709219 A BR 9709219A BR 9709219 A BR9709219 A BR 9709219A BR 9709219 A BR9709219 A BR 9709219A BR 9709219 A BR9709219 A BR 9709219A
Authority
BR
Brazil
Prior art keywords
hepatodigestive
treatment cells
pinaverium bromide
prevent proliferative
resulting diseases
Prior art date
Application number
BR9709219A
Other languages
English (en)
Inventor
Marie-Odile Christen
Joelle Maugard
Huynh Duc
Hans Scheruebl
Jan Huizinga
Michael G Blennerhasset
Original Assignee
Solvay Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharma filed Critical Solvay Pharma
Publication of BR9709219A publication Critical patent/BR9709219A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9709219A 1996-05-06 1997-05-06 Utilização do brometo de pinaverium na prevenção dos fenômenos proliferativos das células do trata hepatodigestivo e das doenças que daí resultam BR9709219A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9605640A FR2748206B1 (fr) 1996-05-06 1996-05-06 Utilisation de bromure de pinaverium dans la prevention des phenomenes proliferatifs des cellules du tractus hepatodigestif et des maladies qui en resultent
PCT/FR1997/000809 WO1997041859A1 (fr) 1996-05-06 1997-05-06 Utilisation du bromure de pinaverium dans la prevention des phenomenes proliferatifs des cellules du tractus hepatodigestif et des maladies qui en resultent

Publications (1)

Publication Number Publication Date
BR9709219A true BR9709219A (pt) 1999-08-10

Family

ID=9491870

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709219A BR9709219A (pt) 1996-05-06 1997-05-06 Utilização do brometo de pinaverium na prevenção dos fenômenos proliferativos das células do trata hepatodigestivo e das doenças que daí resultam

Country Status (10)

Country Link
US (1) US6500826B1 (pt)
EP (1) EP0900084B1 (pt)
AU (1) AU2902397A (pt)
BR (1) BR9709219A (pt)
CA (1) CA2254395C (pt)
ES (1) ES2236806T3 (pt)
FR (1) FR2748206B1 (pt)
HU (1) HU225886B1 (pt)
PT (1) PT900084E (pt)
WO (1) WO1997041859A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040244062A1 (en) * 2003-06-02 2004-12-02 Crittenden Jill R. Use of protein inhibitors as antithrombotic agents
WO2006136391A2 (en) * 2005-06-23 2006-12-28 Novartis Ag Treatment of solid tumor disease with combinations comprising imatinib and an efflux pump inhibitor
EP2020234B1 (en) * 2006-03-09 2012-04-25 World Trade Import-Export, WTIE A.G. Synergic combination of pinaverium bromide and dimethicone or simethicone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2097032B1 (pt) * 1970-07-29 1973-08-10 Berri Balzac
DE3922387A1 (de) * 1989-07-07 1991-01-17 Kali Chemie Pharma Gmbh N-benzyl-n-((1s,5s)-6,6-dimethylbicyclo/3.1.1/hept-2-ylaethoxy-aethyl)-morpholinium-salze enthaltende gastroprotektiv wirksame pharmazeutische zubereitungen

Also Published As

Publication number Publication date
HU225886B1 (hu) 2007-11-28
EP0900084B1 (fr) 2005-03-30
HUP9902593A3 (en) 2000-04-28
WO1997041859A1 (fr) 1997-11-13
FR2748206B1 (fr) 1998-07-31
HUP9902593A2 (hu) 2000-02-28
EP0900084A1 (fr) 1999-03-10
CA2254395C (fr) 2007-10-23
CA2254395A1 (fr) 1997-11-13
US20020193413A1 (en) 2002-12-19
ES2236806T3 (es) 2005-07-16
FR2748206A1 (fr) 1997-11-07
US6500826B1 (en) 2002-12-31
PT900084E (pt) 2005-08-31
AU2902397A (en) 1997-11-26

Similar Documents

Publication Publication Date Title
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
NO942283L (no) Pyrofeoforbider og deres anvendelse i fotodynamisk terapi
EE9700039A (et) Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
DE69529926D1 (de) Wegwerfwindel in Höschenform
FI942333A0 (fi) Silyylillä silloitetut metalloseenit ja niiden käyttö
GB9515775D0 (en) Piperidine derivatives and their use as therapeutic agents
NO982913D0 (no) Kinolin- og kinazolinforbindelser nyttige i terapi
NO2005006I2 (no) Anvendelse av tomoksetin ved behandling av ADHD
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
LV11868A (lv) Kermena svara modulatori to pielietojums diagnostika un terapija
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
FI944600A0 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
ID20600A (id) Sel-sel yang dimodifikasi secara genetik dan penggunaannya dalam profilaksis atau terapi penyakit
ID18679A (id) Penggunaan terapi lanjutan
BR9705645A (pt) Metalocenos sua preparacão e utilizacão na polimeracão de alfa-alefinas
PT764157E (pt) Benzopiranos e sua utilizacao como agentes terapeuticos
FI954964A (fi) vWF-pitoisten konsentraattien käyttö yhdistelmäterapiana antitromboottisilla ja fibrinolyyttisillä lääkeaineilla suoritettavassa terapiassa
BR9709219A (pt) Utilização do brometo de pinaverium na prevenção dos fenômenos proliferativos das células do trata hepatodigestivo e das doenças que daí resultam
FI973185A0 (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
PT922703E (pt) Benzocicloalcenos substituidos e sua utilizacao como substancias com efeito analgesico
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
EE9900135A (et) N-(2-bensotiasolüül)-1-piperidiinetaanamiini derivaadid, nende valmistamine ja kasutamine raviks
DE69528261D1 (de) Benzopyrane und deren verwendung als therapeutische mittel
NO20010044L (no) Anvendelse av texafyriner i makrofag-medierte sykdommer
BR9508519A (pt) Pregnanos e colanos como iniciadores neuroquímicos de alteração na função hipotalâmica

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: SOLVAY PHARMA S.A.S. (FR)

Free format text: TRANSFERIDO DE: SOLVAY PHARMA